Safety, Efficacy and Pharmacokinetic Behavior of Leuprolide Injectable Emulsion for Premenopausal Breast Cancer Subjects.

NCT06449027 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

211

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer Subjects

Interventions

DRUG: T Leuprolide Injectable Emulsion
DRUG: Leuprorelin Acetate Microspheres for Injection

Sponsor

Changchun GeneScience Pharmaceutical Co., Ltd.